Berkeley Lights' Beacon Platform
Berkeley Lights has launched its Beacon platform, which accelerates cell line development and empowers immuno-oncology research. The new platform is powered by BLI's OptoSelect technology, which enables the precise movement, positioning, and interaction of cells on an opto-fluidic chip. Its automated workflows can shorten the typical development timeline by as much as three months, the company said. The platform also enables researchers to work at a single cell level with B-cells, multiple types of T-cells, myeloid cells, and other cells of interest.